A Study of Longer Interval of IVT IBI302 in Subjects With nAMD

Clinical trial NCT05403749 · COMPLETED

Trial details

NCT number: NCT05403749
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration

Start date: 2022-06-29
Primary completion: 2024-05-13
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.